| Particulars |
|
|
|
| Company Name
| Beta Drugs Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
10.14 |
B.V. (₹) |
147.50 |
| Sales(₹ Cr.) |
225.43 |
NP (₹ Cr.) |
14.33 |
| NP Var% |
-24.00 |
Div% |
0.00 |
| CPS(₹) |
23.70 |
EPS (₹) |
14.10 |
| Traded Value(₹ Lakhs) |
0.00 |
52 Week High |
2,000.00 |
| 52 Week Low |
990.00 |
Price BSE |
0.00 |
| Price NSE |
1,771.00 |
Market Capital (₹ Cr.) |
1,795.45 |
| P/C Ratio |
74.80 |
P/E Ratio |
125.20 |
| Price Vs.BV |
12.01 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
54.35 |
| NP(₹ Cr.) |
5.33 |
NP Var % |
78.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var% |
-23.56 |
EPS |
14.14 |
| PE |
125.26 |
|
|